Hendrik Schulze-Koops Selected Research

Hendrik Schulze-Koops Research Topics

Disease

38	Rheumatoid Arthritis 04/2022 - 01/2002
13	Rheumatic Diseases (Rheumatism) 09/2021 - 01/2012
10	COVID-19 01/2022 - 01/2020
9	Infections 01/2022 - 05/2011
8	Inflammation (Inflammations) 01/2021 - 09/2002
8	Autoimmune Diseases (Autoimmune Disease) 06/2015 - 09/2002
5	Psoriatic Arthritis 12/2020 - 12/2006
5	Arthritis (Polyarthritis) 11/2019 - 10/2010
4	Neoplasms (Cancer) 11/2021 - 02/2008
4	Necrosis 01/2021 - 08/2014
4	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2020 - 01/2019
4	Disease Progression 09/2019 - 04/2014
2	Adult-Onset Still's Disease 01/2020 - 09/2012
2	Giant Cell Arteritis (Horton Disease) 01/2019 - 01/2017
2	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 02/2015 - 11/2012
2	Vasculitis (Vasculitides) 11/2012 - 05/2011
2	Pemphigus (Pemphigus Vulgaris) 10/2012 - 05/2011
1	Gastroenteritis 01/2022
1	Appendicitis 01/2022
1	Abscess 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Sarcoidosis (Schaumann Disease) 11/2021
1	Kidney Diseases (Kidney Disease) 09/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 06/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2021
1	Myalgia 09/2019
1	Cough 09/2019
1	Headache (Headaches) 09/2019
1	Heartburn (Pyrosis) 09/2019
1	Anaphylaxis (Anaphylactic Shock) 01/2019
1	Hypersensitivity (Allergy) 01/2019
1	Takayasu Arteritis (Arteritis, Takayasu's) 02/2018
1	Fever (Fevers) 01/2018
1	Arthralgia (Joint Pain) 01/2018
1	Synovitis 01/2018
1	Axial Spondyloarthritis 11/2017
1	Fatigue 01/2017
1	Chronic Disease (Chronic Diseases) 01/2017
1	Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy) 01/2017
1	Sialadenitis 12/2015

Drug/Important Bio-Agent (IBA)

14	Antirheumatic Agents (DMARD)IBA 01/2021 - 10/2010
13	Biological ProductsIBA 01/2021 - 10/2002
12	Rituximab (Mabthera)FDA Link 10/2021 - 11/2005
11	GlucocorticoidsIBA 01/2022 - 10/2010
7	tofacitinibIBA 04/2022 - 08/2012
6	Methotrexate (Mexate)FDA LinkGeneric 10/2021 - 01/2018
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012 - 02/2005
5	tocilizumab (atlizumab)FDA Link 01/2022 - 01/2017
5	Janus Kinase InhibitorsIBA 01/2022 - 08/2012
5	Biosimilar PharmaceuticalsIBA 01/2019 - 01/2017
5	Monoclonal AntibodiesIBA 11/2017 - 11/2005
4	Adalimumab (Humira)FDA Link 12/2020 - 01/2012
4	CytokinesIBA 09/2020 - 01/2002
3	Immunologic Factors (Immunomodulators)IBA 01/2022 - 08/2012
3	Oxygen (Dioxygen)IBA 01/2022 - 01/2021
3	Etanercept (Enbrel)FDA Link 01/2019 - 01/2012
3	golimumab FDA Link 01/2016 - 08/2014
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2015
2	baricitinibIBA 01/2022 - 07/2019
2	VaccinesIBA 11/2021 - 01/2021
2	Immune Checkpoint InhibitorsIBA 11/2021 - 05/2019
2	Tumor Necrosis Factor InhibitorsIBA 10/2021 - 11/2017
2	ixekizumabIBA 12/2020 - 10/2020
2	InterleukinsIBA 01/2020 - 02/2014
2	GP2015IBA 01/2019 - 01/2018
2	AntibodiesIBA 01/2019 - 06/2008
2	C-Reactive ProteinIBA 01/2018 - 07/2012
2	Infliximab (Remicade)FDA Link 01/2018 - 01/2012
2	Prednisone (Sone)FDA LinkGeneric 01/2018 - 01/2017
2	amsonic acid (DAS)IBA 01/2017 - 04/2014
2	secukinumabIBA 01/2016 - 02/2014
2	Antiviral Agents (Antivirals)IBA 09/2013 - 11/2010
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2012 - 05/2011
2	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 12/2006 - 05/2006
1	ianalumabIBA 01/2022
1	Interleukin-1 (Interleukin 1)IBA 01/2022
1	IpilimumabIBA 11/2021
1	ORALIT (ORS)IBA 01/2021
1	Abatacept (Orencia)FDA Link 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	canakinumab FDA Link 01/2020
1	Immunomodulating AgentsIBA 01/2020
1	NivolumabIBA 11/2019
1	EnzymesIBA 09/2019
1	Genetic Markers (Genetic Marker)IBA 09/2019
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2019
1	ametantrone (HAQ)IBA 01/2017
1	interleukin-6 receptor alphaIBA 01/2017
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2016
1	Immunoglobulin G (IgG)IBA 12/2015
1	MicroRNAs (MicroRNA)IBA 06/2015

Therapy/Procedure

19	Therapeutics 01/2022 - 02/2008
4	Immunotherapy 11/2021 - 11/2005
2	Immunomodulation 01/2022 - 01/2021